Optos
  • Products
  • Patients
  • Providers
  • About Us
  • Contact
  • Customers
  • Virtual Booth
  • News
  • Media
  • Events
  • Careers
  • Search
  • Toggle side navigation
  • Virtual Booth
  • News
  • Media
  • Events
  • Careers
Home > Clinical Outcomes

Clinical Outcomes

optomap imaging takes less than half a second...
to uncover critical information

optomap ultra-widefield imaging is a proven tool for effective clinical decision making.More than 400 published and ongoing clinical trials, as well as thousands of case studies and testimonials, show the long-term value of optomap imaging in diagnosis, treatment planning, and patient engagement

The non-mydriatic, ultra-widefield optomap technology delivers detailed 200° images in less than half a second. 

optomap is a proven tool for effective clinical decision making.

Additional clinical information

View our complete image library

Contact Our Clinical Team

Focus: Uveitis image

Focus: Uveitis

 
Key Results:

optomap color images altered management in 19%, optomap fa an additional 13% (6 of 43), combined color and optomap fa altered management in a total of 48% (21 of 43 patients) overall. Disease activity was detected in 63% (27 of 43) patients when using ultra-widefield imaging when compared with 51% (22 of 43) based on examination and simulated conventional FA.  

Read Summary
Focus: Diabetic Retinopathy image

Focus: Diabetic Retinopathy


Key Results:

optomap had perfect agreement with the long-standing ETDRS gold standard.

Read Summary
Focus: Diabetic Retinopathy and Disease Progression image

Focus: Diabetic Retinopathy and Disease Progression


Key Results:

Eyes with predominantly peripheral lesions (defined as outside of ETDRS 7 standard field) had a 4.7 fold increased risk of progression to proliferative diabetic retinopathy (PDR) and Eyes with predominantly peripheral lesions had a 3.2 fold risk of 2 step progression in DR.

Read Summary
Focus: AMD and Lesions in the Periphery image

Focus: AMD and Lesions in the Periphery


Key Results:

A study published in Ophthalmology found that optomap confirmed the presence of wide-ranging AMD-like pathologic changes even in those without central sight-threatening macular disease. 67% of patients with age-related macular degeneration (AMD) had peripheral retinal changes associated with AMD.

Read Summary
Focus: The Evolution of UWF Imaging in Clinical Applications image

Focus: The Evolution of UWF Imaging in Clinical Applications


Key Results:

A comprehensive review published in Retina describes how ultra-widefield is evolving to become the standard of care imaging modality for many diseases and is finding new clinical and research applications such as for screening and telemedicine.

Read Summary
Focus: Using UWF for Pediatrics image

Focus: Using UWF for Pediatrics


Key Results:

Results published in Eye showed for the first time that Optos non-contact ultra-widefield imaging can obtain high-quality images in ROP. 

Read Summary
Focus: UWF Compared with DFE image

Focus: UWF Compared with DFE


Key Results:

A study published in Eye and Brain suggests that adding an optomap to a traditional BIO exam may improve sensitivity by up to 30%.

Read Summary
Focus: Identifying Peripheral Changes Using UWF ICG image

Focus: Identifying Peripheral Changes Using UWF ICG


Key Results:

A study published in Retina finds that optomap icg was found to demonstrate high image quality, comparable in the central pole to competitive products and peripheral changes were visualized outside of 68° field of view in 69% of eyes evaluated.

Read Summary
Focus: Telemedicine Applications image

Focus: Telemedicine Applications


Key Results:

Ocular screening programs which include optomap imaging have a higher rate of diabetic retinopathy detection and more effectively identify patients at high risk for progression. 

Read Summary
Focus: Spectralis image

Focus: Spectralis


Key Results:

On a single nonsteered image, the Optos optomap covered a significantly larger total retinal surface area, with greater image variability, than did the Heidelberg Spectralis ultra-widefield module. The Optos captured an appreciably wider view of the retina temporally and nasally.

Read Summary

You are now leaving the Global site. To change your language, make a selection at the bottom of the page.

Ok Cancel

You are now leaving the Global site. To change your language, make a selection at the bottom of the page.

Ok Cancel
Deutsch flagDeutsch Français flagFrançais
English flagEnglish
  • Distributor Portal
  • Find a Doctor
  • Registered in Scotland
  • Blog
  • Unsubscribe
  • Manage Preferences
  • Privacy
  • UK Modern Slavery Act
  • Cookie Policy

© 2022 Optos. Optos, optos and optomap are registered trademarks of Optos plc. UWF is an Optos trademark.